Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians

Croatian Medical Journal

Volumn 49, Issue 1, 2008, Pages 39-49

  Spiroski, Igor ^a   Kedev, Sashko ^a   Antov, Slobodan ^a   Arsov, Todor ^a   Krstevska, Marija ^a   Dzhekova Stojkova, Sloboda ^a   Kostovska, Stojanka ^b   Trajkov, Dejan ^a   Petlichkovski, Aleksandar ^a   Strezova, Ana ^a   Efinska Mladenovska, Olivija ^a   Spiroski, Mirko ^a,c  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b Institute of Transfusion Medicine   (Macedonia)

^c SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEEP VEIN THROMBOSIS; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; MACEDONIA (REPUBLIC); MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POLYMORPHISM, GENETIC; VENOUS THROMBOSIS;

EID: 40449097464     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2008.1.39     Document Type: Article

References (41)

1. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7:195-200. Medline:7920641 doi:10.1038/ng0694-195
2. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome. 1998;9:652-6. Medline:9680386 doi:10.1007/s003359900838
3. Online Mendelian Inheritance in Man. OMIM (TM). Available from: http://www.ncbi.nlm.nih.gov/omim/. Accessed: January 30, 2008.
4. Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, Pessotto R, et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood. 1998;91:4158-63.
5. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58:35-41.
6. Akar N, Akar E, Akçay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res. 2000;97:163-7. Medline:10680647 doi:10.1016/S0049-3848(99)00157-7
7. Cronin S, Furie KL, Kelly PJ. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke. 2005;36:1581-7. Medline:15947278 doi:10.1161/01.STR.0000169946.31639.af
8. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a metaanalysis. Neurology. 2003;59:529-36.
9. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, et al. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002;288:2023-31. Medline:12387655 doi:10.1001/jama.288.16.2023
10. Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ. 2005;331:1053. Medline:16216822 doi:10.1136/bmj.38611.658947.55
11. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 2007;4:e131. Medline:17455988 doi:10.1371/journal.pmed.0040131
12. Keijzer MB, Borm GF, Blom HJ, Bos GM, Rosendaal FR, den Heijer M. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. Thromb Haemost. 2007;97:32-7.
13. Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ, et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. Med Genetik. 2004;41:454-8. doi:10.1136/jmg.2003.017244
14. Towner P. Purification of DNA. In: Brown TA, editor. Essential molecular biology. Oxford: Oxford University Press; 1995. p. 47-54.
15. Spiroski M, Arsov T, Petlichkovski A, Strezova A, Trajkov D, Efinska-Mladenovska O, et al. Case Study: Macedonian Human DNA Bank (hDNAMKD) as a source for public health Genetics. In: Georgieva L, Burazeri G, editors. Health determinants in the scope of new public health. Sofia: Hans Jacobs Co; 2005. p. 33-44.
16. Mahfouz RA, Sabbagh AS, Shammaa DM, Otrock ZK, Zaatari GS, Taher AT. Factor XIII gene V34L mutation in the Lebanese population: Another unique feature in this community? Mol Biol Rep. 2007 May 22 [Epub ahead of print].
17. Lancaster A, Nelson MP, Meyer D, Thomson G, Single RM. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomput. 2003;:514-25.
18. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. PyPop update - a software pipeline for large-scale multilocus population genomics. Tissue Antigens. 2007;69 Suppl 1:192-7. Medline:17445199 doi:10.1111/j.1399-0039.2006. 00769.x
19. Single RM, Meyer D, Mack SJ, Lancaster A, Erlich HA, Thomson G. 14th International HLA and Immunogenetics Workshop: report of progress in methodology, data collection, and analyses. Tissue Antigens. 2007;69 Suppl 1:185-7. Medline:17445197 doi:10.1111/j.1399-0039.2006.00767.x
20. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 1992;48:361. Medline:1637966 doi:10.2307/2532296
21. Schneider S, Roessli D, Excoffier L. Arlequin version 2.000: a software for population genetics data analysis. Geneva (Switzerland): Genetics and Biometry Laboratory, University of Geneva; 2000.
22. Watterson GA. The homozygosity test of neutrality. Genetics. 1978;88:405-17.
23. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity. 1996;76:377-83.
24. Slatkin M. An exact test for neutrality based on the Ewens sampling distribution. Genet Res. 1994;64:71-4.
25. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics. 1987;117:331-41.
26. Grandone E, Corrao AM, Colaizzo D, Vecchione G, Di Girgenti C, Paladini D, et al. Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat Diagn. 2006;26:1-5. Medline:16374895 doi:10.1002/pd.1359
27. Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C, et al. The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr. 2003;133:1281-5.
28. Cesari M, Zanchetta M, Burlina A, Pedon L, Maiolino G, Sticchi D, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol. 2005;25:115-21.
29. Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism. 2001;50:640-5. Medline:11398138 doi:10.1053/meta.2001.23286
30. Zuntar I, Topic E, Vukosavic D, Vukovic V, Demarin V, Begonja A, et al. Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups. Clin Chim Acta. 2003;335:95-100. Medline:12927690 doi:10.1016/S0009-8981(03)00283-3
31. Papoutsakis C, Yiannakouris N, Manios Y, Papaconstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in Greek children are influenced by an interaction between the methylenetetrahydrofolate reductase C677T genotype and folate status. J Nutr. 2005;135:383-8.
32. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet. 2003;40:619-25. Medline:12920077 doi:10.1136/jmg.40.8.619
33. Zalavras ChG, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tzolou A, et al. Lack of association between the C677T mutation in the 5,10- methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol. 2002;21:268-71.
34. Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, März W, Bode G, et al. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis. 2002;162:193-200. Medline:11947914 doi:10.1016/S0021-9150(01)00699-2
35. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res. 2001;102:115-20. Medline:11323021 doi:10.1016/S0049-3848(01)00226-2
36. Franco RF, Morelli V, Lourenço D, Maffei FH, Tavella MH, Piccinato CE, et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol. 1999;105:556-9. Erratum in: Br J Haematol. 1999;106:264. doi:10.1046/j.1365-2141.1999.106001264. x
37. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032-6.
38. van Bockxmeer FM, Mamotte CD, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation. 1997;95:21-3.
39. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation. 1997;96:412-7.
40. Kebert CB, Eichner JE, Moore WE, Schechter E, Yaoi T, Vogel S, et al. Relationship of the 1793G-A and 677C-T polymorphisms of the 5,10- methylenetetrahydrofolate reductase gene to coronary artery disease. Dis Markers. 2006;22:293-301.
41. Pare G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet. 2007;80:673-82. Medline:17357073 doi:10.1086/513286